Dx Deals: BD Laboratory Business Is Up for Grabs in Bold Move
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.
Understanding the 2024 CLFS update—and the changes that are still to come.
What clinical validation really means—and why every member of the laboratory should understand it.
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.
What 2023 Q3 earnings from 30 key US lab companies indicate about the current state of the industry and outlook for 2024.
Labs, patients, and technology must all work together to deliver forward-thinking patient-centered care.